Embryonal Tumors with Multilayer Rosettes – Rare Central Nervous System Tumors in Infants
Authors:
M. Pleško 1; K. Husáková 1; E. Kaiserová 1; M. Tichý 2; J. Zámečník 3
Authors place of work:
Klinika detskej hematológie a onkológie LF UK a DFNsP Bratislava, Slovenská republika
1; Neurochirurgická klinika dětí a dospělých 2. LF UK a FN v Motole, Praha
2; Laboratoř neuropatologie, Ústav patologie a molekulárni medicíny, 2. LF UK a FN v Motole, Praha
3
Published in the journal:
Klin Onkol 2015; 28(4): 288-292
Category:
Case Report
doi:
https://doi.org/10.14735/amko2015288
Summary
Introduction:
The most recent findings show a histopathological, genetic and clinical uniformity in cases of tumors called embryonal tumors with multilayer rosettes. This group is composed of medulloepithelioma, ependymoblastoma and embryonal tumor with abundant neuropil and true rosettes. Amplification of locus 19q13.42, which includes C19MC cluster containing genes for microRNA, and also LIN28A positivity are present in all three entities. Dysregulation of epigenetic modifiers is very important in pathogenesis of the disease. These tumors manifest in little children (median less than 3 years of age); overall survival is 5–10%.
Case report:
Almost three year-old boy diagnosed with brainstem tumor: meduloepithelioma, WHO grade IV confirmed by histological investigation. He presented with dysarthria, bulbar syndrome, central lesion of the facial nerve, quadriparesis with right-side dominancy. He received three induction cycles of chemotherapy from March to May 2014 (according to protocol COG ACNS0334). Only partial improvement of his clinical state was reached. Signs of an intracranial hypertension appeared resulting in VP shunt insertion; impairment of consciousness developed after the induction cycles and before any other treatment could be initiated. He underwent radiotherapy due to vital indication. After application of two fractions (boost in the center of the tumor), the patient became quickly comatose. Spinal cord metastasis was demarked by MRI scan (in the level of 3rd cervical vertebra). A bilateral infiltration in pulmonary parenchyma, according to a radiologist metastasis-wise, was detected by CT scan (histologisation of infiltration was not implemented). The patient died in August 2014 – six months after manifestation of first symptoms.
Conclusion:
We reported our first documented case of a patient with tumor from embryonal tumors with multilayer rosettes group in Slovakia. Nowadays, there is no effective treatment of these tumors. Research of molecules targeting to epigenetic modifiers would be one of the possible promises for future therapy.
Key words:
medulloepithelioma – ependymoblastoma – embryonal tumors with multilayer rosettes – microRNA – 19q13.42 – C19MC – LIN28
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.
Submitted:
26. 5. 2015
Accepted:
24. 6. 2015
Zdroje
1. Kaiserová E. Nádory centrálneho nervového systému. In: Ondruš D et al (eds). Všeobecná a špeciálna onkológia. 1. vyd. Bratislava: Polygrafické stredisko UK 2006: 278– 280.
2. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114(2): 97– 109.
3. Eberhart CG, Brat DJ, Cohen KJ et al. Pediatric neuroblastic tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 2000; 3(4): 346– 352.
4. Ryzhova MV, Kushel YV, Zheludkova OG et al. Medulloepithelioma, ependymoblastoma and embryonal tumor with multilayered rosettes: Are the Same Disease Entity? N N Burdenko J Neurosurgery 2013; 77(6): 45– 48.
5. Ferri Niguez B, Martinez‑ Lage JF, Almagro MJ et al. Embryonal tumor with neuropil and true rosettes (ETANTR): a new distinctive of pediatric PNET: a case‑based update. Childs Nerv Syst 2010; 26(8): 1003– 1008. doi: 10.1007/ s00381‑ 010‑ 1179‑ x.
6. Adamek D, Sofowora KD, Cwiklinska M et al. Embryonal tumor with abudant nuropil and true rosettes: an autopsy case‑based update and review of the literature. Childs Nerv Syst 2013; 29(5): 849– 854. doi: 10.1007/ s00381‑ 013‑ 2037‑ 4.
7. Gessi M, Giangaspero F, Lauriola L et al. Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 2009; 33(2): 211– 217. doi: 10.1097/ PAS.0b013e318186235b.
8. Woehrer A, Slavc i, Peyrl A et al. Embryonal tumor with abundant neuropil ant true rosettes (ETANTR) with loss of morphological but retained genetic key features during progression. Acta Neuropathol 2011; 122(6): 787– 790. doi: 10.1007/ s00401‑ 011‑ 0903‑ 2.
9. Li M, Lee KF, Lu Y et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 2009; 16(6): 533– 546. doi: 10.1016/ j.ccr.2009.10.025.
10. Pfister S, Remke M, Castoldi M et al. Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. Acta Neuropathol 2009; 117(4): 457– 464. doi: 10.1007/ s00401‑ 008‑ 0467‑ y.
11. Korshunov A, Ryzhova M, Jones TW et al. LIN28Aimmunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 2012; 124(6): 875– 881. doi: 10.1007/ s00401‑ 012‑ 1068‑ 3.
12. Paulus W, Kleihues P. Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol 2010; 120(2): 269– 270. doi: 10.1007/ s00401‑ 010‑ 0710‑ 1.
13. Khatua S, Brown R, Pearlman M et al. ETANTR – tumor with undefined biology. Neuro‑Oncology 2012; 14: 143– 148.
14. Korshunov A, Sturm D, Ryzhova M et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 2014; 128(2): 279– 289. doi: 10.1007/ s00401‑ 013‑ 1228‑ 0.
15. Robertson KD. DNA metylation, methyltransferases, and cancer. Oncogene 2001; 20(24): 3139– 3155.
16. Ioshikhes IP, Zhang MQ. Large‑ scale human promoter mapping using CpG islands. Nat Genet 2000; 26(1): 61– 63.
17. Suganuma T, Workman JL. Crosstalk among histone modifications. Cell 2008; 135(4): 604– 607. doi: 10.1016/ j.cell.2008.10.036.
18. Hamano R, Miyata H, Yamaski M et al. High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer. Br J Cancer 2012; 106(8): 1415– 1423. doi: 10.1038/ bjc.2012.90.
19. Molenaar JJ, Domingo‑ Fernandez R, Ebus ME et al. LIN28B induces neuroblastoma and enhances MYCN levels via let‑ 7 suppression. Nat Genet 2012; 44(11): 1199– 1206. doi: 10.1038/ ng.2436.
20. Spence T, Perotti C, Sin‑Chan P et al. A novel C19MC amplified cell line links LIN28/ let7 to mTOR signaling in embryonal tumor with multilayered rosettes. Neuro Oncol 2014; 16(1): 62– 71. doi: 10.1093/ neuonc/ not162.
21. Huang J, Chen K, Huang J et al. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. Carcinogenesis 2009; 30(2): 348– 355. doi: 10.1093/ carcin/ bgn266.
22. Spence T, Sin‑Chan P, Picard D et al. CNS‑ PNETS with C19MC amplification and/ or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol 2014; 128(2): 291– 303. doi: 10.1007/ s00401‑ 014‑ 1291‑ 1.
23. Komiya Y, Habas R. Wnt signal transduction pathway. Organogenesis 2008; 4(2): 68– 75.
24. Braiteh F, Soriano AO, Garcia‑ Manero G et al. Phase I study of epigenetic modulation with 5- azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res 2008; 14(19): 6296– 6301. doi: 10.1158/ 1078‑ 0432.CCR‑ 08‑ 1247.
25. Sin‑Cahn P, Huang A. DNMTs as potential therapeutic targets in high‑risk pediatric embryonal brain tumors. Expert Opin Ther Targets 2014; 18(10): 1103– 1107. doi: 10.1517/ 14728222.2014.938052.
Štítky
Paediatric clinical oncology Surgery Clinical oncologyČlánok vyšiel v časopise
Clinical Oncology
2015 Číslo 4
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- Possibilities of Using Metamizole in the Treatment of Acute Primary Headaches
- Current Insights into the Antispasmodic and Analgesic Effects of Metamizole on the Gastrointestinal Tract
Najčítanejšie v tomto čísle
- Extraoseus Ewing‘s Sarcoma, Primary Affection of Uterine Cervix – Case Report
- Embryonal Tumors with Multilayer Rosettes – Rare Central Nervous System Tumors in Infants
- Potential of Cell‑free Circulating DNA in Diagnosis of Cancer
- Estimated Glomerular Filtration Rate in Oncology Patients before Cisplatin Chemotherapy